Beijing Strong Biotechnologies,Inc.’s Net Profit Rose 9.6% in First Quarter of 2023
Listen to the full version

Beijing Strong Biotechnologies,Inc. (北京九强生物技术股份有限公司) (300406.SZ) reported a net profit of 109.9 million yuan in the first quarter of 2023, up 9.6% year-on-year.
Meanwhile, the company posted 373.4 million yuan in revenue, up 0.2% year-on-year.
At the end of the reporting period, it had 4.7 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 28%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR